scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BIOMATERIALS.2005.08.030 |
P698 | PubMed publication ID | 16146647 |
P50 | author | Oju Jeon | Q58782309 |
P2093 | author name string | Ji Hyung Chung | |
Byung-Soo Kim | |||
Sun-Woong Kang | |||
Hee-Won Lim | |||
P433 | issue | 8 | |
P1104 | number of pages | 10 | |
P304 | page(s) | 1598-1607 | |
P577 | publication date | 2005-09-16 | |
P1433 | published in | Biomaterials | Q15751139 |
P1476 | title | Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel | |
P478 | volume | 27 |
Q53477371 | Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system. |
Q47427231 | Arginine functionalization of hydrogels for heparin binding--a supramolecular approach to developing a pro-angiogenic biomaterial |
Q92508854 | Bioactive Medications for the Delivery of Platelet Derivatives to Skin Wounds |
Q47165579 | Bioinspired Heparin Nanosponge Prepared by Photo-crosslinking for Controlled Release of Growth Factors. |
Q39291722 | Co-transplantation of bone marrow-derived mesenchymal stem cells and nanospheres containing FGF-2 improve cell survival and neurological function in the injured rat spinal cord |
Q36005075 | Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration |
Q33603057 | Control growth factor release using a self-assembled [polycation:heparin] complex |
Q39754529 | Controlled and sustained gene delivery from injectable, porous PLGA scaffolds. |
Q35162409 | Controlled protein delivery in the generation of microvascular networks. |
Q48009478 | Controlled release of basic fibroblast growth factor for angiogenesis using acoustically-responsive scaffolds. |
Q38068244 | Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery |
Q57337767 | Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering |
Q50847623 | Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide. |
Q47880097 | Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide |
Q46813976 | Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease |
Q64110064 | Differentiation of Bone Marrow Mesenchymal Stem Cells into Neural Lineage Cells Induced by bFGF-Chitosan Controlled Release System |
Q50440578 | Effect of a Scaffold Fabricated Thermally from Acetylated PLGA on the Formation of Engineered Cartilage |
Q27333474 | Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles |
Q35600150 | Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration |
Q50949843 | Engineered adipose tissue formation enhanced by basic fibroblast growth factor and a mechanically stable environment. |
Q35645763 | Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma |
Q39222465 | Fibrin gels containing GDNF microspheres increase axonal regeneration after delayed peripheral nerve repair |
Q38030641 | From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering |
Q51158186 | Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. |
Q43952051 | Heparin-conjugated poly(lactic-co-glycolic acid) nanospheres enhance large-wound healing by delivering growth factors in platelet-rich plasma |
Q38643959 | Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. |
Q82322545 | Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor |
Q46410876 | Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2). |
Q36400508 | Human Urine-derived Stem Cells Seeded Surface Modified Composite Scaffold Grafts for Bladder Reconstruction in a Rat Model |
Q35639514 | Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model |
Q50518747 | In situ cardiomyogenic differentiation of implanted bone marrow mononuclear cells by local delivery of transforming growth factor-β1. |
Q38135949 | Incorporation of heparin into biomaterials |
Q37960809 | Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. |
Q45919200 | Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold. |
Q50230512 | Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model |
Q37562012 | Locally delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs |
Q39083233 | Medical application of glycosaminoglycans: a review |
Q36198788 | Microsecond-pulsed dielectric barrier discharge plasma stimulation of tissue macrophages for treatment of peripheral vascular disease |
Q38152204 | Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery |
Q42114375 | Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration |
Q47700878 | Multilayered pore-closed PLGA microsphere delivering OGP and BMP-2 in sequential release patterns for the facilitation of BMSCs osteogenic differentiation |
Q37470319 | Nanoparticulate systems for growth factor delivery |
Q35105415 | Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery |
Q36748503 | Nanotechnology in the diagnosis and management of heart, lung and blood diseases. |
Q41500114 | Novel Method for Loading Microporous Ceramics Bone Grafts by Using a Directional Flow. |
Q37471639 | Potential of hydrogels based on poly(ethylene glycol) and sebacic acid as orthopedic tissue engineering scaffolds |
Q39273739 | Protein based therapeutic delivery agents: Contemporary developments and challenges |
Q37439946 | Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles |
Q50962974 | Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems. |
Q37841416 | Standardization of models and methods used to assess nanoparticles in cardiovascular applications |
Q38537491 | Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review |
Q43048909 | Synthesis and characterization of Poloxamer 188-grafted heparin copolymer |
Q34377496 | Synthesis and characterization of UPPE-PLGA-rhBMP2 scaffolds for bone regeneration |
Q30449821 | Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease |
Q37195004 | The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds |
Q37909452 | The use of micro- and nanospheres as functional components for bone tissue regeneration |
Q58909325 | Therapeutic Angiogenesis of PLGA-Heparin Nanoparticle in Mouse Ischemic Limb |
Q38037091 | Therapeutic angiogenesis for treating cardiovascular diseases |
Q55638524 | Therapeutic neovascularization promoted by injectable hydrogels. |
Q36294602 | Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization |
Q42071394 | Tunable Controlled Release of Bioactive SDF-1α via Protein Specific Interactions within Fibrin/Nanoparticle Composites |
Search more.